Remove tag ai-healthcare
article thumbnail

PharmaShots Weekly Snapshots (March 20 - 24, 2023)

PharmaShots

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 64
article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year. Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space.

Hospitals 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Cerner 111
article thumbnail

Viseven at Reuters Pharma EU

Viseven

Notably, the focus of pharma companies never shifted from customer-centric approach, although the rise of AI technologies was probably the hottest issue of the event. Innovation never stops, so upon returning from Barcelona we moved on to prepare to the China Digital Healthcare Innovation Summit and MarTech Summit in Singapore!

article thumbnail

PharmaShots Weekly Snapshots (March 20 - 24, 2023)

PharmaShots

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 40
article thumbnail

Disruptive Tech in Pharma: A Future of Digital Interactions

Viseven

Jay Rabheru , Head of Marketing, Agency Services, Life Science and Healthcare,? Dr. Geetha Thiagarajan , CTO Lifesciences and Healthcare business unit,? Now with the pandemic, the whole access to the healthcare ecosystem was limited or even blocked. What does it mean??. So that’s where pharma should be focused on.

52
article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

It stands to reason that if the EHR makes records more readily available at the point of care, then the same EHR in the hands of a PharmD/chronic care coordinator who has this kind of AI software can deliver better care between visits and further benefit the practice. Adverse drug events are avoided. Joseph Guglielmo, PharmD. Dean, Troy C.